OpenAI has brought Codex preview controls to the ChatGPT mobile app, letting iPhone and Android users review, approve, and ...

As soon as I checked Control the name, I remembered Control the game by Remedy. Well, this Roblox game is not much different. In Control, you are a C.T.R.L. employee with a badge, a flashlight, and a ...

If you’re running an Nvidia GPU, the Nvidia Control Panel is one of the most powerful, and most overlooked, tools at your disposal. Hidden behind its plain interface are dozens of tweaks that can ...

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for ...

Adds volume and play controls to Instagram videos. This extension adds playback controls to Instagram videos. This allows you to change the volume and seek through the video.

Abstract: With the rapid progress of technology, traditional presenting styles sometimes fail to engage audiences effectively. The search for new ways to improve user engagement has been spurred by ...

Gilead Sciences and Arcus Biosciences’ domvanalimab, one of the last anti-TIGIT antibodies still standing, has failed another trial—leading Gilead to pull further away from their once wide-ranging ...

The Phase 3 failure has prompted Gilead Sciences and Arcus Biosciences to terminate a mid-stage study of their TIGIT asset in lung cancer. Gilead Sciences and Arcus Biosciences are discontinuing a ...

Arcus Biosciences (RCUS) traded lower in the premarket on Monday after the oncology-focused biotech announced the discontinuation of a late-stage trial designed to evaluate its anti-TIGIT therapy ...

Arcus Biosciences is discontinuing a phase 3 lung cancer trial it was conducting with Gilead Sciences. Arcus, an oncology company, said Monday it was ending the trial due to futility, meaning it doesn ...